NETDA Holding Group's portfolio company listed on HKEX
Nantong Economic and Technological Development Area (NETDA) Holding Group's portfolio company, Suzhou Ribo Life Science, was listed on the main board of the Hong Kong Stock Exchange on Jan 9. This makes it the first listed company in Jiangsu province in 2026.
Ribo Life Science is a pioneering powerhouse in the field of global RNA interference technology development and the industrialization of small nucleic acid drugs.
The company has established an independent full-technology-chain R&D platform and built a globally integrated development system, with its pipeline covering multiple chronic disease categories such as cardiovascular, metabolic, renal, and liver diseases.
This listing ranks as a major achievement based on the investment by NETDA Holding Group through its cooperative sub-fund, Shenzhen Xinchuang Yihe. The group aims to continue focusing on strategic emerging industries, deepening the integration of industry and investment, and promoting the industrial upgrading and high-quality economic development of the zone.
NETDA Holding Group's portfolio company, Suzhou Ribo Life Science, is listed on the main board of the HKEX on Jan 9. [Photo/WeChat account: gh_78ba52d6e1ed]
